Nodal T-follicular helper cell lymphoma, follicular type

Last reviewed March 21, 2026

🖨 Print for my doctor Advocacy Hub →

ORPHA:652650C82.7

Who is this for?

Show terms as

2Active trials 9Specialists 8Treatment centers

Where are you in your journey?

ℹ

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.

Report missing data

Overview

Also known as:

Nodal T-cell lymphoma with TFH phenotype Follicular T-cell Lymphoma nTFHL-F Follicular helper T-cell lymphoma, follicular type Nodal TFH lymphoma, follicular type

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events

Jun 2026Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

City of Hope Medical Center — PHASE2

TrialNOT YET RECRUITING

Jun 2026A Study of LY4152199 in Participants With Previously Treated B-cell Cancers (BAF_FRontier-1 )

Eli Lilly and Company — PHASE1

TrialNOT YET RECRUITING

Feb 2026huCART19-IL18-eDHFR Cells in Relapsed/Refractory Follicular Lymphoma

University of Pennsylvania — PHASE1

TrialNOT YET RECRUITING

Aug 2025Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

Joseph Tuscano — PHASE2

TrialRECRUITING

Jun 2025A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

GenomeFrontier Therapeutics TW Co., Ltd. — PHASE1

TrialRECRUITING

Apr 2024Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)

Sana Biotechnology — PHASE1

TrialACTIVE NOT RECRUITING

Dec 2023Relmacabtagene Autoleucel in Hematologic Malignancies

Shanghai Ming Ju Biotechnology Co., Ltd.

TrialNOT YET RECRUITING

Nov 2023Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)

Peking University — PHASE2

TrialRECRUITING

Jan 2023AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH

Tianjin Medical University Cancer Institute and Hospital — PHASE3

TrialENROLLING BY INVITATION

Sep 2022Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

Sun Yat-sen University — PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Nodal T-follicular helper cell lymphoma, follicular type.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →

Phase 21 trial

Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)

Phase 2

Actively Recruiting

PI: PING WEI LIU, Master (Peking University Cancer Hospital & Institute) · Sites: Beijing, Beijing Municipality · Age: 18–65 yrs

Specialists

9 foundView all specialists →

SM

Suresh Mahabhashyam, MD, MPH

Specialist

Aggressive primary cutaneous T-cell lymphoma

PI on 2 active trials

Active trials Directions Travel grants

PP

Paolo Corradini, Prof

Specialist

PI on 1 active trial

Active trials Directions Travel grants

LH

Leona Holmberg

SEATTLE, WA

Specialist

Acute myeloid leukemia with 11q23 abnormalities Autoimmune/inflammatory optic neuropathy Cerebrotendinous xanthomatosis+14 more

PI on 8 active trials

Active trials Directions Travel grants

DD

Dehui Zou, Dr.

Specialist

Aggressive B-cell non-Hodgkin lymphoma B-cell non-Hodgkin lymphoma Classic Hodgkin lymphoma

PI on 5 active trials

Active trials Directions Travel grants

SS

Sonali Smith

CHICAGO, IL

Specialist

Acute lymphoblastic leukemia Aggressive B-cell non-Hodgkin lymphoma Lymphomatoid granulomatosis

PI on 5 active trials130 Nodal T-follicular helper cell lymphoma, follicular type publications

Active trials Directions Travel grants

JM

Jeremy Abramson, MD

BOSTON, MA

Specialist

Anaplastic large cell lymphoma Angioimmunoblastic T-cell lymphoma Classic Hodgkin lymphoma+2 more

PI on 5 active trials

Active trials Directions Travel grants

BS

Bistol-Myers Squibb

Specialist

ALK-negative anaplastic large cell lymphoma ALK-positive anaplastic large cell lymphoma Breast implant-associated anaplastic large cell lymphoma

PI on 1 active trial

Active trials Directions Travel grants

ER

Eric Rowinsky

BOCA RATON, FL

Specialist

PI on 1 active trial

Active trials Directions Travel grants

CP

Christina Poh

DUARTE, CA

Specialist

PI on 1 active trial

Active trials Directions Travel grants

Treatment Centers

8 centers

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Nodal T-follicular helper cell lymphoma, follicular type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Nodal T-follicular helper cell lymphoma, follicular typeForum →

No community posts yet. Be the first to share your experience with Nodal T-follicular helper cell lymphoma, follicular type.

Start the conversation →

Latest news about Nodal T-follicular helper cell lymphoma, follicular type

Disease timeline:

New recruiting trial: Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients

A new clinical trial is recruiting patients for Nodal T-follicular helper cell lymphoma, follicular type

New recruiting trial: Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

A new clinical trial is recruiting patients for Nodal T-follicular helper cell lymphoma, follicular type

New recruiting trial: Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

A new clinical trial is recruiting patients for Nodal T-follicular helper cell lymphoma, follicular type

New recruiting trial: Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)

A new clinical trial is recruiting patients for Nodal T-follicular helper cell lymphoma, follicular type

New recruiting trial: Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype

A new clinical trial is recruiting patients for Nodal T-follicular helper cell lymphoma, follicular type

New recruiting trial: A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

A new clinical trial is recruiting patients for Nodal T-follicular helper cell lymphoma, follicular type

New recruiting trial: Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS)

A new clinical trial is recruiting patients for Nodal T-follicular helper cell lymphoma, follicular type

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Nodal T-follicular helper cell lymphoma, follicular type

Are there clinical trials for Nodal T-follicular helper cell lymphoma, follicular type?

Yes — 2 recruiting clinical trials are currently listed for Nodal T-follicular helper cell lymphoma, follicular type on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Nodal T-follicular helper cell lymphoma, follicular type?

9 specialists and care centers treating Nodal T-follicular helper cell lymphoma, follicular type are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.